Nancy Denyes Biography and Net Worth

The estimated net worth of Nancy Denyes is at least $21.98 thousand as of February 4th, 2025. Denyes owns 26,555 shares of aTyr Pharma stock worth more than $21,982 as of December 5th. This net worth evaluation does not reflect any other assets that Denyes may own. Additionally, Denyes receives an annual salary of $518,200.00 as General Counsel at aTyr Pharma. Learn More about Nancy Denyes' net worth.

Denyes is currently 56 years old. There are 3 older executives and no younger executives at aTyr Pharma. The oldest executive at aTyr Pharma is Dr. David J. King Ph.D., Scientific Consultant, who is 65 years old. Learn More on Nancy Denyes' age.

As the General Counsel of aTyr Pharma, Inc., Denyes earns $518,200.00 per year. There are 2 executives that earn more than Denyes. The highest earning executive at aTyr Pharma is Dr. Sanjay S. Shukla M.D., M.S., President, CEO & Director, who commands a salary of $768,180.00 per year. Learn More on Nancy Denyes' salary.

The corporate mailing address for Denyes and other aTyr Pharma executives is 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121. aTyr Pharma can also be reached via phone at (858) 731-8389 and via email at [email protected]. Learn More on Nancy Denyes' contact information.

Nancy Denyes has not been actively trading shares of aTyr Pharma during the past quarter. Most recently, Nancy Denyes sold 899 shares of the business's stock in a transaction on Tuesday, February 4th. The shares were sold at an average price of $3.78, for a transaction totalling $3,398.22. Following the completion of the sale, the general counsel now directly owns 26,555 shares of the company's stock, valued at $100,377.90. Learn More on Nancy Denyes' trading history.

aTyr Pharma's insider roster includes Jill Broadfoot (CFO), Nancy Denyes (General Counsel), Jane Gross (Director), and Paul Schimmel (Director). Learn More on aTyr Pharma's active insiders.